Sulphimides as protein kinase inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C544S323000

Reexamination Certificate

active

07943629

ABSTRACT:
The invention relates to sulphimides as protein kinase inhibitors of the general formula I

REFERENCES:
patent: 2005/0176743 (2005-08-01), Luecking et al.
patent: WO 2005/037800 (2005-04-01), None
Simone, Oncology: Introduction, Cecil Textbook of Medicine, 20thEdition, vol. 1, pp. 1004-1010, 1996.
Cohen et al., Current Opinion in Chemical Biology, 3, 459-465, 1999.
Dermer et al., Bio/Technology, 1994, 12:320.
Freshney et al., Culture of Animal Cells, A Manual of Basic Technique, Alan R. Liss, Inc., 1983, New York, pp. 1-6.
Golub et al., Science, 266, 531-537, 1993.
Mass, R.D., Int. J. Radiation Oncology Bio Phys. vol. 58(3):932-940, 2004.
Fabbro et al., Pharmacology & Therapeutics 93 (2002), pp. 79-98.
Powell et al., British Journal of Dermatology, 141:802-810, 1999.
Tohru Ueda, et al.; “Nucleosides XVII. Pyrimidinyl Amino Acids”; J. Med Chem.; 1963; Bd. 6; pp. 697-700.
Simon F. Campbell, et al.; “2, 4-Diamino-6,7,-dimethoxyquinazolines.3. 2-(4-heterocyclylpiperazin-1-yl) derivatives . . . ” J. Med. Chem.; 1987; Bd. 30; pp. 1794-1798.
Polina I. Svirskaya, et al.; “Fluorinated heterocyclic compounds. 2. 2, 4-difluoro and 4-amino-2-fluoropyrimidines, nucleoside base analogs”; J. Heterocycl. Chem.; 1985; pp. 149-153.
Giorgio Caravatti, et al.; “Structure based design of a non-peptidic antagonist of the SH2 domain of GRB2”; Bioorg. Med. Chem. Lett.; 1999; pp. 1973-1978; Bd. 9.
G.B. Barlin; “Kinetics of reactions in heterocycles”; J. Chem. Soc. (B); 1967; pp. 954-958.
Kondratenko, et al.; “S-trifluoromethyl-S-aryl-N-trifluoromethylsulfonylsulfimides”; Zhurnal Organicheskoi Khimii; 1984; pp. 2599-2604; Bd. 20, Nr. 12; Chemical Abstracts Service, Database accession No. 102:220513.
Kenneth K. Andersen, et al.; “Antimalarial sulfilimines and sulfoximines related to diaminodiphenyl sulfoxide and sulfone”; J. Med. Chem.; 1970; pp. 759-760; Bd. 13, Nr. 4.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Sulphimides as protein kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sulphimides as protein kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulphimides as protein kinase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2693009

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.